top of page

Press Release: Plano Pharmaceuticals Announces FDA Approval for Generic Drug Product

Plano Pharmaceuticals, a leading specialty injectable and blow-fill-seal (BFS) pharmaceutical company, is excited to announce the FDA approval of our latest generic drug product. This milestone achievement showcases our commitment to developing high-quality medications that increase patient access and affordability.

The newly approved generic drug product represents a significant addition to our growing portfolio, which includes niche high added value and high barrier entry products, as well as volume products. By expanding our offerings, we aim to address unmet medical needs and provide healthcare providers with cost-effective solutions without compromising quality or efficacy.

Plano Pharmaceuticals' dedication to excellence in research, development, and regulatory compliance has been instrumental in obtaining this FDA approval. We remain focused on leveraging our expertise and industry partnerships to continue delivering innovative pharmaceutical solutions that improve patient outcomes and transform healthcare.



bottom of page